The headline number from mid-2026 is technically encouraging: hospital revenue is growing. But revenue figures have a way of obscuring what’s actually happening on the margin line and right now […]
Read More
At Blue & Co., we believe that our greatest strength lies in our people. Each member of our Medicare Bad Debt team brings a unique blend of expertise, experience, and […]
Read More
Beginning June 7, 2024, Indiana Medicaid launched a transformative new program: PathWays, a managed long-term service and support (MLTSS) initiative designed to streamline care for aging Hoosiers. This program partners […]
Read More
Are you maximizing your reimbursement potential with Medicare Advantage (MA) plans? Many healthcare providers are unaware that they can file bad debt listings for additional reimbursement. The key lies in […]
Read More
To appeal or not to appeal: that is the question. Medicare cost report appeals can be extremely profitable, but which issues are worth the time and effort to appeal? Without […]
Read More
The new Medicare Bad Debt template (Exhibit 2A) and S-10 template (Exhibit 3B and 3C) have been finalized by Medicare and are now required for cost reporting periods ending on […]
Read More
This article has been updated on January 5, 2023. Back in August 2022, CMS was proposing changes to the Medicare Bad Debt listing template that is filed with your organization’s […]
Read More
How to Protect Dual Eligible Reimbursement from Audit Scrutiny In the past year, there has been a new audit trend emerging amongst MACs (Medicare Administrative Contractors). In some cases, this […]
Read More
Since the release of Centers for Medicare & Medicaid (CMS) final ruling, there has been a lot of confusion regarding the correct way to write off a bad debt crossover […]
Read More
In these unprecedented times, protecting your Medicare bad debt reimbursement is more important than ever. With decreases in patient volume due to COVID-19, hospitals will certainly feel the effect on […]
Read More
Unrelated business income (UBI) remains one of the most fact-intensive areas of federal tax compliance for all exempt-organizations, particularly healthcare organizations. As health systems diversify revenue, expand ancillary services, and […]
By Jonah Gjertson, Senior Consultant at Blue & Co. Starting Point The first half of 2026 has remained relatively stable among the public dealership groups, with new profit per vehicle […]
This summer, the Centers for Medicare and Medicaid Services (CMS) proposed two new rules that, if finalized, will have significant financial and operational impacts on 340B covered entities. In early […]
Copyright © 2026, Blue & Co., LLC.
All Rights Reserved.
